Journal Title：Journal Of Managed Care & Specialty Pharmacy

JMCP welcomes research studies conducted outside of the United States that are relevant to our readership. Our audience is primarily concerned with designing policies of formulary coverage, health benefit design, and pharmaceutical programs that are based on evidence from large populations of people. Studies of pharmacist interventions conducted outside the United States that have already been extensively studied within the United States and studies of small sample sizes in non-managed care environments outside of the United States (e.g., hospitals or community pharmacies) are generally of low interest to our readership. However, studies of health outcomes and costs assessed in large populations that provide evidence for formulary coverage, health benefit design, and pharmaceutical programs are of high interest to JMCP’s readership.

JMCP 歡迎在美國境外進行與我們的讀者相關的研究。我們的讀者主要關注基于大量人群的證據而設計處方集覆蓋、健康福利設計和藥物計劃的政策。在美國境外進行的藥劑師干預研究（這些研究已在美國境內進行了廣泛研究）以及在美國境外非管理式醫療環境（例如醫院或社區藥房）中進行的小樣本研究通常不會引起我們的讀者的興趣。但是，在大量人群中評估的健康結果和成本研究為處方集覆蓋、健康福利設計和藥物計劃提供了證據，這對 JMCP 的讀者來說很有吸引力。

Journal Of Managed Care & Specialty Pharmacy創刊于2014年，由Academy of Managed Care Pharmacy (AMCP)出版商出版，收稿方向涵蓋Health Professions - Pharmacy全領域，此期刊水平偏中等偏靠后，在所屬細分領域中專業影響力一般，過審相對較易，如果您文章質量佳，選擇此期刊，發表機率較高。平均審稿速度 ，影響因子指數2.3，該期刊近期沒有被列入國際期刊預警名單，廣大學者值得一試。